USMJ And PURA Add FAQ To New ACI Website To Address Dividend Shares Among Other Shareholder Inquires
September 14 2017 - 9:08AM
InvestorsHub NewsWire
Dallas, Texas - September
14, 2017 – North American Cannabis Holdings, Inc. (USOTC:
USMJ) and Puration, Inc. (USOTC: PURA)
today announced adding a new FAQ page to the consolidated American
Cannabis Conglomerated (“ACI) website launched earlier this
week. ACI recently acquired the controlling shareholder
interest in both USMJ and PURA with plans to acquire shareholder
interests in additional cannabis industry entrepreneurial
companies. The FAQ section addresses several common questions
received in emails and voicemails to include inquiries regarding
the PURA common stock distributed in a dividend distribution to
USMJ shareholders last December (2016). The new FAQ section
also includes replies to questions regarding the availability of
EVERx CBD Infused Sports water and questions about the combined
companies’ new communication plan. Look for the FAQ section
to be updated regularly. View the new FAQ section and the
link below:
ACI FAQ PAGE FOR USMJ AND
PURA
Review Website For Important Updates and
Changes
The new website includes important updates and details on
organizational and strategic changes. The reorganization of
operations under ACI is already underway. USMJ and PURA are
already adopting new go-to-market strategies and additional
operational and marketing changes are anticipated soon. The
website includes information regarding recent, pending and
anticipated strategic and operational changes.
Learn more about ACI, USMJ and PURA by visiting:
aciconglomerated.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any disease.
ACI, USMJ and PURA contact info to include email, phone and
address:
https://www.aciconglomerated.com/contact/
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024